EXCITE: A PHASE II TRIAL OF PREOPERATIVE CETUXIMAB, IRINOTECAN AND CAPECITABINE PLUS RADIOTHERAPY (RT) IN MRI-DEFINED LOCALLY ADVANCED RECTAL CANCER (LARC)

被引：0
|
作者：
Gollins, S. [1 ]
Myint, A. S. [2 ]
Saunders, M. P. [3 ]
Susnerwala, S. [4 ]
Sebag-Montefiori, D. [5 ]
Beare, S. [6 ]
Williams, E. [6 ]
West, N. [5 ]
Jitlal, M. [6 ]
机构：
[1] N Wales Canc Treatment Ctr, Rhyl, Wales
[2] Clatterbridge Canc Ctr, Liverpool, Merseyside, England
[3] Christie Hosp NHS Fdn Trust, Manchester, Lancs, England
[4] Royal Preston Hosp, Preston, Lancs, England
[5] Univ Leeds, Leeds, W Yorkshire, England
[6] UCL, CR UK & UCL Canc Trials Ctr, London, England
来源：
ANNALS OF ONCOLOGY | 2012年 / 23卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：206 / 207
页数：2
相关论文
共 50 条
  • [1] ARISTOTLE: A phase III trial comparing concurrent capecitabine with capecitabine and irinotecan (Ir) chemoradiation as preoperative treatment for MRI-defined locally advanced rectal cancer (LARC).
    Sebag-Montefiore, David
    Adams, Richard
    Gollins, Simon
    Samuel, Leslie M.
    Glynne-Jones, Robert
    Harte, Robert
    West, Nicholas
    Quirke, Philip
    Myint, Arthur Sun
    Bach, Simon P.
    Parsons, Philip
    Falk, Stephen
    Dhadda, Amandeep Singh
    Misra, Vivek
    Brown, Nick
    Brown, Gina
    Harrison, Mark
    White, Laura
    Duggan, Marian
    Lopes, Andre
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [2] Preoperative downstaging chemoradiation with concurrent irinotecan and capecitabine in MRI-defined locally advanced rectal cancer: a phase I trial (NWCOG-2)
    Gollins, S. W.
    Myint, S.
    Susnerwala, S.
    Haylock, B.
    Wise, M.
    Topham, C.
    Samuel, L.
    Swindell, R.
    Morris, J.
    Mason, L.
    Levine, E.
    BRITISH JOURNAL OF CANCER, 2009, 101 (06) : 924 - 934
  • [3] Preoperative downstaging chemoradiation with concurrent irinotecan and capecitabine in MRI-defined locally advanced rectal cancer: a phase I trial (NWCOG-2)
    S W Gollins
    S Myint
    S Susnerwala
    B Haylock
    M Wise
    C Topham
    L Samuel
    R Swindell
    J Morris
    L Mason
    E Levine
    British Journal of Cancer, 2009, 101 : 924 - 934
  • [4] Phase I/II study of preoperative cetuximab, capecitabine and external beam radiotherapy in patients with locally advanced rectal cancer (LARC)
    Machiels, J.
    Coche, J.
    Scalliet, P.
    Van Cutsem, E.
    Roels, S.
    Canon, J.
    Coster, B.
    Kerger, J.
    Remouchamps, V.
    Haustermans, K.
    EJC SUPPLEMENTS, 2005, 3 (02): : 183 - 183
  • [5] Phase II XERT trial: Neoadjuvant cetuximab, capecitabine and radiotherapy (RT) in locally advanced resectable rectal cancer
    Velenik, V.
    Ocvirk, J.
    Oblak, I.
    Anderluh, F.
    EJC SUPPLEMENTS, 2009, 7 (02): : 327 - 327
  • [6] Neoadjuvant cetuximab, capecitabine, and radiotherapy (RT) in locally advanced resectable rectal cancer: results of a phase II trial
    Velenik, V.
    Ocvirk, J.
    Oblak, I.
    Anderluh, F.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [7] Preoperative Treatment with Capecitabine, Cetuximab and Radiotherapy for Primary Locally Advanced Rectal Cancer - A Phase II Clinical Trial
    Eisterer, Wolfgang
    De Vries, Alexander
    Oefner, Dietmar
    Rabl, Hans
    Koplmueller, Renate
    Greil, Richard
    Tschmelitsch, Joeerg
    Schmid, Rainer
    Kapp, Karin
    Lukas, Peter
    Sedlmayer, Felix
    Hoefler, Gerald
    Gnant, Michael
    Thaler, Josef
    ANTICANCER RESEARCH, 2014, 34 (11) : 6767 - 6773
  • [8] CETUXIMAB IN COMBINATION WITH CAPECITABINE, IRINOTECAN, AND RADIOTHERAPY FOR PATIENTS WITH LOCALLY ADVANCED RECTAL CANCER: RESULTS OF A PHASE II MARGIT TRIAL
    Horisberger, Karoline
    Treschl, Anne
    Mai, Sabine
    Barreto-Miranda, Manuel
    Kienle, Peter
    Stroebel, Philipp
    Erben, Philipp
    Woernle, Christoph
    Dinter, Dietmar
    Kaehler, Georg
    Hochhaus, Andreas
    Post, Stefan
    Willeke, Frank
    Wenz, Frederik
    Hofheinz, Ralf-Dieter
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2009, 74 (05): : 1487 - 1493
  • [9] Cetuximab in combination with capecitabine, irinotecan and concurrent radiotherapy (CAPIRI-RT) for preoperative treatment of locally advanced rectal cancer
    Hofheinz, RD
    Horisberger, K
    Tiefenbacher, U
    Wenz, F
    von Gerstenberg, B
    Kähler, G
    Post, S
    Hochhaus, A
    Willeke, F
    ANNALS OF ONCOLOGY, 2006, 17
  • [10] Phase II study of capecitabine and radiotherapy (RT) plus concomitant boost in patients (pts) with locally advanced rectal cancer (LARC).
    Shi, GG
    Lin, E
    Eng, C
    Delcos, M
    Crane, C
    Amos, CB
    Brown, T
    Abbruzzese, JL
    Skibber, J
    Janjan, N
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 312S - 312S
12345